Kemnay Advisory Services Inc. Horizon Therapeutics Public LTD CO Transaction History

Kemnay Advisory Services Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $925,786 - $1.03 Million	-10,735 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $25,858 - $34,372	-360 Reduced 3.24%	10,735 $988,000
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $743,365 - $936,307	11,095 New	11,095 $812,000
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $638,514 - $924,070	-11,561 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $349,142 - $658,745	11,561 New	11,561 $643,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Kemnay Advisory Services Inc., based on Form 13F filings with the SEC.

Stay updated on Kemnay Advisory Services Inc. with notifications on news.